by Jeff Hawes, PharmD
Pharmacy Benefit Consultant
Pharmaceutical Strategies Group

It is often thought that simply increasing the copayment for chronic-condition drugs will result in better overall savings for plan sponsors. Recent evidence, however, suggests otherwise. Studies are showing that, as plans increase member copayments, there is a decrease in member’s therapeutic compliance resulting in higher long-term treatment expenses. Conversely, making medications more affordable for specific chronic disease states results in substantial overall savings.

by Connie Perry, PharmD
National Pharmacy Practice Leader
Trivantage Pharmacy Strategies, LLC

Although there are varying degrees as to how to best define a specialty pharmacy medication, the most common attributes include a high cost, legend drug that requires special handling and administration, temperature controlled shipping, and careful adherence to treatment protocols. What does not vary today, however, is the large financial and clinical impact these particular medications have on plan sponsors and members alike.

by Craig Stern, PharmD, MBA, President
Pro Pharma Pharmaceutical Consultants, Inc

What do we want in our pharmacy benefit management contracts? How can we be sure that critical elements are included in contracts? As with any vendor contract there are specific elements that must be included to ensure that we are receiving the services and pricing that are consistent with our business requirements.